Emirati Jiu-Jitsu stars win 23 medals, athletes grab 11 medals, and People of Determination excel with 14 medals
Japan has approved the Covid-19 pill developed by US pharmaceutical company Merck & Co. for use beginning next week, the Japanese health minister said Friday.
Health Minister Shigeyuki Goto told reporters that a ministry drug panel authorized Merck’s molnupiravir under a fast-track process and the drug will be shipped to hospitals and pharmacies beginning next week.
ALSO READ:
It’s one of two medications for treating Covid-19 that Japan has secured. Prime Minister Fumio Kishida said the country is procuring 1.6 million doses from Merck.
Japan has also arranged for a shipment of 2 million doses of a Covid-19 pill made by Pfizer that hasn’t yet received approval for use in the country.
Until recently, Japan largely kept out coronavirus infections involving the new omicron variant by enforcing stringent border controls. The first known locally transmitted cases were reported in Osaka on Wednesday.
More cases were reported Friday in Osaka and neighbouring Kyoto, while Tokyo reported its first community-acquired omicron case.
Emirati Jiu-Jitsu stars win 23 medals, athletes grab 11 medals, and People of Determination excel with 14 medals
The first of seven phases, Friday's vote covered 166 million voters in 102 constituencies across 21 states and territories
The unique showcase brings together a diverse lineup of comedians from India and Pakistan, promising an hour of non-stop entertainment
Work teams across all customs centres continued to process cargo clearance and inspections
The UN chief urges international community to work together to prevent any actions that could push the entire Middle East over the edge
This punishment sent out a message to all teams of the importance of maintaining a healthy pace throughout a match
Only 10 of Gaza's 36 hospitals are currently even partially functioning
The updated Meta AI assistant will be given more prominent billing within Meta's Facebook, Instagram, WhatsApp and Messenger apps